rais pt industri trend rais comp
commerci anim health
vaccin product also provid product
servic relat biodevic diagnost
tool genet
requir disclosur end report
view current cl king meet event calendar coverag univers
follow strong earn cycl rais price target zoeti
see rise comp across space although admit
share expens side think risk/return favor
compar name anim health ah space core thesi
zoeti grow revenu via strong companion anim
product maintain stabl perform livestock busi
drive earn growth effici initi base
stabl strong cash flow dividend share repurchas view
stabl long-term grower attract market reiter buy rate
rais price target
companion anim growth thesi zoeti growth come
signific growth larg product ah play well remain
growth ahead apoquel ctyopoint simparica companion
anim busi grew clip significantli competitor
elanco part eli lilli nr saw neg growth
bayer bayzf nr report growth although zoeti lap
tough compar year industri growth rate
flea tick bayer report growth flea tick collar seresto
although growth like offset loss topic flea tick
repel advantag elanco launch credelio howev price
drug closer market leader bravecto nexgard despit
market without superior label see simparica label fairli
compar leader think zoeti simparica continu
take share even use lower price strategi
livestock recal zoeti report growth livestock sale
driven cattl posit develop particularli competitor
elanco report declin product anim chiefli around market
access competit pressur posilac optiflexx respect
think zoeti posit livestock strong posit
fish vaccin expect strong growth zoeti acquisit pharmaq
recal zoeti purchas produc fish vaccin expect
incom competit elanco clynav global demand fish protein
support multipl product space net net fish protein
remain sourc upsid view
comp price idxxa neoga
 abaxi abaxa hskaa trade ep
comfort say better valu play understand
abax high growth rate potenti
oper leverag believ zoeti dividend share buyback
coupl lead market posit give lower contract risk new
price target base price-to-earnings multipl
adjust ep estim increas
multipl reflect increas multipl aforement comp
risk achiev price target
price concess competit
strong growth prospect outsid
page
